- Home
- VRDN vs EH Comparison
VRDN vs EH Comparison
Compare VRDN & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- EH
- Stock Information
- Founded
- VRDN 2006
- EH 2014
- Country
- VRDN United States
- EH China
- Employees
- VRDN N/A
- EH N/A
- Industry
- VRDN Medical Specialities
- EH Military/Government/Technical
- Sector
- VRDN Health Care
- EH Industrials
- Exchange
- VRDN Nasdaq
- EH Nasdaq
- Market Cap
- VRDN 1.6B
- EH 1.3B
- IPO Year
- VRDN N/A
- EH 2019
- Fundamental
- Price
- VRDN $21.65
- EH $19.09
- Analyst Decision
- VRDN Strong Buy
- EH Strong Buy
- Analyst Count
- VRDN 11
- EH 3
- Target Price
- VRDN $38.80
- EH $24.80
- AVG Volume (30 Days)
- VRDN 658.9K
- EH 1.4M
- Earning Date
- VRDN 11-11-2025
- EH 11-17-2025
- Dividend Yield
- VRDN N/A
- EH N/A
- EPS Growth
- VRDN N/A
- EH N/A
- EPS
- VRDN N/A
- EH N/A
- Revenue
- VRDN $305,000.00
- EH $65,001,814.00
- Revenue This Year
- VRDN N/A
- EH $16.86
- Revenue Next Year
- VRDN $34,076.08
- EH $87.98
- P/E Ratio
- VRDN N/A
- EH N/A
- Revenue Growth
- VRDN 5.90
- EH 87.04
- 52 Week Low
- VRDN $9.90
- EH $12.02
- 52 Week High
- VRDN $27.20
- EH $29.76
- Technical
- Relative Strength Index (RSI)
- VRDN 66.74
- EH 64.48
- Support Level
- VRDN $20.83
- EH $17.77
- Resistance Level
- VRDN $19.97
- EH $20.20
- Average True Range (ATR)
- VRDN 0.92
- EH 0.78
- MACD
- VRDN 0.18
- EH 0.21
- Stochastic Oscillator
- VRDN 91.56
- EH 68.15
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.